The Food and Drug Administration (FDA) this week approved a blood test for colorectal cancer screening in average-risk adults aged 45 and older. Known as Shield, it is the first blood test to receive FDA approval as a primary screening method for colorectal cancer and to qualify for Medicare reimbursement, according to a press release. While the price has not been announced, the test is expected to reach the market within a week. Shield will …
Read More![New Blood Test Offers Option For Colorectal Cancer Screening New Blood Test Offers Option For Colorectal Cancer Screening](https://www.jucm.com/wp-content/uploads/2024/07/Blood-Test-Young-White-Female-Provider-with-Stethoscope-Around-Neck-Giving-Bloos-Test-or-Shot-to-Over-Grey-Haired-White-Male-Cancer-test-380x253-1.jpg)